Canada vs Norway: Proportion of isolates with resistance to azithromycin reported to
Canada
6.1
in 2020
Norway
7.6
in 2020
Canada rank
25th
Norway rank
23rd
Proportion of isolates with resistance to azithromycin reported to over time
- Canada
- Norway
How they compare
Norway currently reports 7.6 against 6.1 in Canada, a difference of 1.5.
That makes Norway's figure about 1.2 times Canada's.
The two have swapped places 2 times across 10 shared years of data; in 2010 it was Norway ahead.
Canada ranks 25th and Norway ranks 23rd of 47 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.17 | 13.04 | 8.86 | Norway |
| 2020s | 6.1 | 7.6 | 1.5 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Canada or Norway?
- Norway, at 7.6 against 6.1 in Canada as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Canada and Norway?
- 1.5, with Norway ahead.
- How many years of comparable data are there for Canada and Norway?
- 10 years are reported by both, from 2010 to 2020.
- How do Canada and Norway rank globally for proportion of isolates with resistance to azithromycin reported to?
- Canada ranks 25th and Norway ranks 23rd of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.